Cogenics has been re-certified, for the third year, as a Certified Microarray Service Provider for Agilent gene expression microarrays
Agilent Technologies and Cogenics, a division of Clinical Data, have announced that Cogenics has been re-certified, for the third year, as a Certified Microarray Service Provider for Agilent gene expression microarrays, and that certification has been extended to include Agilent array-based comparative genomic hybridization (aCGH) experiments, an emerging field of study.
Cogenics, a global provider of molecular and pharmacogenomics services to the life sciences community, received the certifications after its laboratory completed training and passed a rigorous set of assessments that included proficiency in analyzing Agilent 60-mer oligo microarrays using the complete Agilent system: sample quality control using the Agilent 2100 Bioanalyzer, sample labeling using Agilent reagents and protocols, hybridization using SureHyb chambers, microarray analysis using the Agilent scanner and feature extraction software, and final data-analysis using the GeneSpring bioinformatics platform.
Drew Fromkin, president and CEO of Clinical Data said, "We're pleased to continue offering a full range of services - from study design to processing to data analysis - that use the Agilent microarray platform.
"Our comprehensive service portfolio and extensive experience with the Agilent platform continues to provide our clients with a full spectrum of solutions for their genomics projects."
